All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

HER2-Negative Metastatic Breast Cancer: Case 1

home / case-based-peer-perspectives / her2neg-mbc-case-1

HER2-Negative Metastatic Breast Cancer

Hatem Soliman, MD: Administering Chemotherapy in MBC

EP. 1: Hatem Soliman, MD: Administering Chemotherapy in MBC

May 20th 2015

Watch

Mateusz Opyrchal, MD, PhD: Administering Chemotherapy in MBC

EP. 2: Mateusz Opyrchal, MD, PhD: Administering Chemotherapy in MBC

May 20th 2015

Watch

Hatem Soliman, MD: Preferred Treatment for HR+ MBC

EP. 3: Hatem Soliman, MD: Preferred Treatment for HR+ MBC

May 20th 2015

Watch

Mateusz Opyrchal, MD, PhD: Preferred Treatment for HR+ MBC

EP. 4: Mateusz Opyrchal, MD, PhD: Preferred Treatment for HR+ MBC

May 20th 2015

Watch

Hatem Soliman, MD: Treating Rapidly Progressing MBC

EP. 5: Hatem Soliman, MD: Treating Rapidly Progressing MBC

May 20th 2015

Watch

Mateusz Opyrchal, MD, PhD: Treating Rapidly Progressing MBC

EP. 6: Mateusz Opyrchal, MD, PhD: Treating Rapidly Progressing MBC

May 20th 2015

Watch

Hatem Soliman, MD: Treating Recurrent MBC

EP. 7: Hatem Soliman, MD: Treating Recurrent MBC

May 20th 2015

Watch

Mateusz Opyrchal, MD, PhD: Treating Recurrent MBC

EP. 8: Mateusz Opyrchal, MD, PhD: Treating Recurrent MBC

May 20th 2015

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.